Insider Transactions in Q2 2021 at Quest Diagnostics Inc (DGX)
Insider Transaction List (Q2 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
May 25
2021
|
Denise M Morrison Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,363
+20.75%
|
-
|
|
May 25
2021
|
Helen Torley Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,363
+17.88%
|
-
|
|
May 25
2021
|
Timothy L Main Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,363
+6.11%
|
-
|
|
May 25
2021
|
Wright Lassiter Iii Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,363
+29.35%
|
-
|
|
May 25
2021
|
Gail R Wilensky Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,363
+7.1%
|
-
|
|
May 25
2021
|
Timothy M Ring Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,363
+5.78%
|
-
|
|
May 25
2021
|
Gary M Pfeiffer Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,363
+5.53%
|
-
|
|
May 21
2021
|
Vicky B Gregg Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,363
+8.13%
|
-
|
|
May 18
2021
|
Michael J Deppe SVP, Corp. Controller & CAO |
SELL
Payment of exercise price or tax liability
|
Direct |
5
-0.02%
|
$680
$136.6 P/Share
|
|
May 07
2021
|
Catherine T. Doherty EVP, Regional Businesses |
SELL
Open market or private sale
|
Direct |
8,536
-11.05%
|
$1,186,504
$139.96 P/Share
|
|
May 05
2021
|
Michael E Prevoznik SVP & General Counsel |
SELL
Open market or private sale
|
Direct |
44,939
-52.81%
|
$6,156,643
$137.0 P/Share
|
|
May 05
2021
|
Michael E Prevoznik SVP & General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
44,939
+34.56%
|
$3,190,669
$71.17 P/Share
|